BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4793143)

  • 1. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
    Pellegrino L; Prencipe D
    Usp Sovrem Biol; 1973; 76(4):827-32. PubMed ID: 4793143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
    Pellegrino L; Prencipe D
    Minerva Cardioangiol; 1973 Dec; 21(12):827-32. PubMed ID: 4780271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)].
    Doshchitsin VL; Golovina TN; Osipova TN
    Kardiologiia; 1973 Mar; 13(3):97-101. PubMed ID: 4123833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Postoperative treatment of acquired valvular disease with atrial fibrillation with disopyramide--with special reference to prevention of recurrence of atrial fibrillation].
    Kito Y; Ohara K; Manabe H
    Kokyu To Junkan; 1982 Nov; 30(11):1157-60. PubMed ID: 7167685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correction of atrial fibrillation with disopyramide].
    Rullière R; Delepierre F
    Coeur Med Interne; 1972; 11(3):581-6. PubMed ID: 4636696
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of rheumatic valvular disease complicated by atrial fibrillation with quinidine in 11 children].
    Xia LP; Mai GR; Xia G
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):256. PubMed ID: 18433565
    [No Abstract]   [Full Text] [Related]  

  • 7. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of Norpace (Part VIII).
    Laidlaw JC
    Angiology; 1975 Jan; 26(1 Pt 2):144-5. PubMed ID: 1090215
    [No Abstract]   [Full Text] [Related]  

  • 11. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.
    Härtel G; Louhija A; Konttinen A
    Clin Pharmacol Ther; 1974 Jun; 15(6):551-5. PubMed ID: 4601741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of the association of acetyldigitoxin and disopyramide in the attack treatment of complete tachyarrhythmia due to auricular fibrillation].
    Lambert B
    Mars Med; 1971; 108(12):851-3. PubMed ID: 5145502
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of repeated electroshock in conversion of atrial fibrillation to sinus rhythm].
    Gavrilescu S; Vicaş E
    Med Interna (Bucur); 1973 May; 25(5):563-71. PubMed ID: 4793892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Decrease in auricular fibrillations by use of disopyramide. 70 trials].
    Rullière R; Vial F; Pornin M
    Nouv Presse Med; 1976 Feb; 5(9):581-2. PubMed ID: 772612
    [No Abstract]   [Full Text] [Related]  

  • 15. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion?
    Stein B; Halperin JL; Fuster V
    Cardiovasc Clin; 1990; 21(1):231-47; discussion 248-9. PubMed ID: 2199050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of rate versus rhythm in rheumatic atrial fibrillation.
    Juneja R; Gulati G
    Indian Heart J; 2004; 56(4):356-7; author reply 357. PubMed ID: 15586750
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies of Norpace (Part VI).
    Pugh DM
    Angiology; 1975 Jan; 26(1 Pt 2):142. PubMed ID: 803799
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical study of circumferential ablation around orifice of pulmonary vein by radiofrequency energy with chronic atrial fibrillation undergoing rheumatic valvular heart surgery].
    Bai BJ; Zhong ZH; Xin LP; Wang CG; Wang JZ; Du RY
    Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(14):946-8. PubMed ID: 17074200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favorable factors in electrocardioversion in atrial fibrillation].
    Serafim L; Iliescu CC
    Med Interna (Bucur); 1970 Jan; 22(1):69-74. PubMed ID: 5527976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.